Miraca Holdings Incorporated operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Miraca Holdings Incorporated with three other
pharmaceutical manufacturers in Asia:
Dr. Lal PathLabs Ltd
sales of 9.12 billion Indian Rupees [US$142.24 million]
(111.24 billion Japanese Yen [US$1.00 billion]
Falco Holdings Co Ltd
(45.97 billion Japanese Yen [US$414.66 million]
Miraca Holdings Incorporated reported sales of ¥204.25 billion (US$1.84 billion)
March of 2017.
decrease of 3.5%
versus 2016, when the company's sales were ¥211.74 billion.